By A large team of researchers affiliated with a host of institutions across the U.S., working with two colleagues from Sweden, reports promising results in a phase I clinical trial aimed at testing the efficacy and safety of an HIV vaccine.
Clinical trial shows promising results for inciting production of neutralizing antibodies in HIV vaccine
Corporate businessmen working on tablet at office
Comments